MODERNA, INC.

MRNA

Real-time Estimate - 01/20 11:34:23 am
122.87USD	-1.71%

Turn to zoom

Prev.	125.0100
Open	124.5100
High	126.0101
Low	122.3500
Volume	16 528 897

19m ago	Novavax : Seoul to procure enough COVID-19 vaccines for North, South Korea
1h ago	WHO plans slew of COVID-19 vaccine approvals for global rollout - document
1h ago	WHO EXPECTS APPROVAL OF MODERNA VACCINE AT END OF FEBRUARY, J&J IN MAY/JUNE...
5h ago	Russia files Sputnik V vaccine registration in Europe

	Short Term	Mid-Term	Long Term
Trend	Bearish	Bullish	Bullish
Resistance	137	170	157
Spread/Res.	-10%	-28%	-22%
Spread/Supp.	18%	26%	144%
Support	104	98,0	50,5

Sales 2020	511 M - -
Net income 2020	-561 M - -
Net cash 2020	2 597 M - -
P/E ratio 2020	-104x
Yield 2020	-

Capitalization	49 468 M 49 468 M -
EV / Sales 2020	91,7x
EV / Sales 2021	4,18x
Nbr of Employees	1 100
Free-Float	90,0%

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:
- Collaboration revenue (79.8%);
- Grant revenue (20.2%).
At the end...

>> Read more

Sector :

Biotechnology & Medical Research - NEC

Calendar :

2021-03-10 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	16
Average target price	136,60 $
Last Close Price	125,01 $
Spread / Highest target	48,0%
Spread / Average Target	9,27%
Spread / Lowest Target	-44,8%